FSA Issues a Warning, CBD List To Be Updated Shortly

The Chief Executive of the Food Standards Agency Emily Miles has warned the CBD industry and retailers that they need to market products responsibly and offered support to local authorities if they need to increase their enforcement efforts on CBD food products in the coming months.

Speaking at the FSA Board meeting on 8 December, Emily Miles laid out the FSA’s proportionate approach to regulating CBD, bringing the industry into compliance with the need for CBD to go through an FSA safety assessment, and the next steps in that process, including updating the CBD public list.

As FSA points out in their press release, there are currently no CBD food products on the market that have been through the mandatory safety assessment and been authorized for sale.

Today the FSA confirmed that the CBD public list will be updated shortly and will be a public record of products where credible applications for market authorization have been made to the FSA. Over the next few months, local authorities and retailers in England and Wales will be able to use the list to check the status of CBD food products and prioritize enforcement where necessary.

”My message to the CBD industry, and to retailers, is that you need to act responsibly when marketing and selling these products. And my message to local authorities is that, as products are rejected from our market authorization process, you may need to step up enforcement efforts. The FSA will support you in this process.”, said Emily Miles, CEO of the FSA.

Speaking on behalf of the Board, Professor Susan Jebb, Chair of the Food Standards Agency said:

“The FSA has a duty to protect consumers. I want to take this opportunity to ask people to think carefully before taking CBD and to follow the FSA’s advice about CBD products. The FSA will not hesitate to take action if evidence emerges that products are unsafe and consumers at great risk.”

Reviewed by Sasha Bajilo, founder of ILESOL Pharmaceuticals, an industrial scale producer of CBD products and formulations. Expert on Hemp/Cannabis policy, member of the Croatian Ministry of Health regulatory commission for medical cannabis.